Importantly, these findings also suggest that IL-1 signaling plays a significant role in the progression of obesity-induced steatosis by activating the lipogenic pathway in hepatocytes. The gene discussed is IL1A; the disease is obesity due to melanocortin 4 receptor deficiency.